These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11904970)

  • 1. [Clinical assessment of monoclonal antibodies for the treatment and diagnosis of colorectal cancers].
    Koda K; Miyazaki M
    Nihon Rinsho; 2002 Mar; 60(3):539-44. PubMed ID: 11904970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.
    Zbar AP; Lemoine NR; Wadhwa M; Thomas H; Snary D; Kmiot WA
    Br J Cancer; 1998 Mar; 77(5):683-93. PubMed ID: 9514045
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic and therapeutic applications of monoclonal antibodies in colorectal cancer.
    Stocchi L; Nelson H
    Dis Colon Rectum; 1998 Feb; 41(2):232-50. PubMed ID: 9556250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.
    Foon KA; John WJ; Chakraborty M; Sherratt A; Garrison J; Flett M; Bhattacharya-Chatterjee M
    Clin Cancer Res; 1997 Aug; 3(8):1267-76. PubMed ID: 9815809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for recurrent colorectal cancers with human monoclonal antibody SK-1.
    Koda K; Glassy MC; McKnight ME; Yasutomi J; Saito N; Dan M; Nakajima N
    Anticancer Res; 2001; 21(1B):621-7. PubMed ID: 11299816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunoscintigraphy of colorectal cancers and specific immunotherapy of pancreatic cancers using monoclonal antibodies].
    Bosslet K; Schwarz A; Steinstraesser A; Kuhlmann L; Seidel L; Schulz G
    Wien Med Wochenschr; 1988 Jun; 138(11-12):255-7. PubMed ID: 3262953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunoscintigraphy in colorectal cancers from the viewpoint of the gastroenterologist].
    Dippold WG; Wittig BM; Hach A; Hahn K; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1990 Dec; 28(12):673-7. PubMed ID: 2087823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian carcinoma therapy with monoclonal antibodies.
    Canevari S; Miotti S; Bottero F; Valota O; Colnaghi MI
    Hybridoma; 1993 Oct; 12(5):501-7. PubMed ID: 8300122
    [No Abstract]   [Full Text] [Related]  

  • 9. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
    Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of genetically-engineered anti-CEA antibodies for potential immunotherapy of colorectal cancer.
    Hardman N; Murray B; Zwickl M; Kolbinger F; Pluschke G
    Int J Biol Markers; 1992; 7(3):203-9. PubMed ID: 1431347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens.
    Sharkey RM; Gold DV; Aninipot R; Vagg R; Ballance C; Newman ES; Ostella F; Hansen HJ; Goldenberg DM
    Cancer Res; 1990 Feb; 50(3 Suppl):828s-834s. PubMed ID: 2297729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technology evaluation: edrecolomab, Centocor Inc.
    Abicht A; Lochmüller H
    Curr Opin Mol Ther; 2000 Oct; 2(5):593-600. PubMed ID: 11249762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy for colorectal cancer.
    Foon KA
    Curr Oncol Rep; 2001 Mar; 3(2):116-26. PubMed ID: 11177743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of a novel anti-colorectal cancer monoclonal antibody, WL5.
    Liu J; Di G; Wu CT; Hu X; Duan H
    Biochem Biophys Res Commun; 2013 Mar; 432(2):370-7. PubMed ID: 23376714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo anticancer efficacy of unconjugated humanized anti-CEA monoclonal antibodies.
    Blumenthal RD; Hansen HJ; Goldenberg DM
    Br J Cancer; 2008 Sep; 99(5):837-8; author reply 839-40. PubMed ID: 18728675
    [No Abstract]   [Full Text] [Related]  

  • 16. The anti-idiotype vaccines for immunotherapy.
    Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
    Curr Opin Mol Ther; 2001 Feb; 3(1):63-9. PubMed ID: 11249733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-EGFR monoclonal antibodies for treatment of colorectal cancers: development of cetuximab and panitumumab.
    You B; Chen EX
    J Clin Pharmacol; 2012 Feb; 52(2):128-55. PubMed ID: 21427284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of colorectal xenografts with combined radioimmunotherapy and tumor blood flow-modifying agents.
    Pedley RB; Boden JA; Boden R; Boxer GM; Flynn AA; Keep PA; Begent RH
    Cancer Res; 1996 Jul; 56(14):3293-300. PubMed ID: 8764124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors.
    Wilkinson RW; Ross EL; Poulsom R; Ilyas M; Straub J; Snary D; Bodmer WF; Mather SJ
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10256-60. PubMed ID: 11517330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of an immune response through the idiotypic network with monoclonal anti-idiotype antibodies in the carcinoembryonic antigen system.
    de Moraes JZ; Carneiro CR; Buchegger F; Mach JP; Lopes JD
    J Cell Biochem; 1992 Nov; 50(3):324-35. PubMed ID: 1281819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.